Omnicell, Inc. (NASDAQ:OMCL) Shares Bought by Louisiana State Employees Retirement System

Louisiana State Employees Retirement System lifted its stake in Omnicell, Inc. (NASDAQ:OMCL) by 3.1% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 15,300 shares of the company’s stock after buying an additional 454 shares during the quarter. Louisiana State Employees Retirement System’s holdings in Omnicell were worth $1,237,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently bought and sold shares of the company. State of Alaska Department of Revenue boosted its holdings in Omnicell by 3.8% during the 1st quarter. State of Alaska Department of Revenue now owns 13,748 shares of the company’s stock valued at $1,111,000 after acquiring an additional 500 shares during the period. Deutsche Bank AG boosted its holdings in Omnicell by 12.0% during the 4th quarter. Deutsche Bank AG now owns 104,867 shares of the company’s stock valued at $6,419,000 after acquiring an additional 11,255 shares during the period. Geode Capital Management LLC boosted its holdings in Omnicell by 7.9% during the 4th quarter. Geode Capital Management LLC now owns 442,184 shares of the company’s stock valued at $27,079,000 after acquiring an additional 32,512 shares during the period. Norges Bank bought a new stake in Omnicell during the 4th quarter valued at $12,125,000. Finally, O Brien Greene & Co. Inc bought a new stake in Omnicell during the 4th quarter valued at $374,000. 95.55% of the stock is currently owned by hedge funds and other institutional investors.

In related news, insider Peter J. Kuipers sold 13,000 shares of the company’s stock in a transaction dated Wednesday, May 8th. The stock was sold at an average price of $81.62, for a total value of $1,061,060.00. Following the completion of the transaction, the insider now owns 55,829 shares of the company’s stock, valued at approximately $4,556,762.98. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Gary S. Petersmeyer sold 750 shares of the stock in a transaction that occurred on Tuesday, February 12th. The shares were sold at an average price of $78.87, for a total value of $59,152.50. The disclosure for this sale can be found here. Insiders sold 188,916 shares of company stock worth $14,362,850 in the last 90 days. Company insiders own 2.77% of the company’s stock.

OMCL has been the subject of a number of research analyst reports. Zacks Investment Research lowered Omnicell from a “hold” rating to a “sell” rating in a research report on Friday, February 15th. Benchmark lifted their target price on Omnicell from $82.00 to $90.00 and gave the company a “buy” rating in a research report on Friday, April 26th. BidaskClub lowered Omnicell from a “hold” rating to a “sell” rating in a research report on Tuesday, April 23rd. Piper Jaffray Companies reissued a “neutral” rating and issued a $70.00 price target on shares of Omnicell in a research report on Friday, February 8th. They noted that the move was a valuation call. Finally, Dougherty & Co boosted their price target on Omnicell from $78.00 to $90.00 and gave the stock a “buy” rating in a research report on Thursday, March 7th. Five analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $79.89.

Omnicell stock traded up $0.62 during trading hours on Friday, hitting $82.41. 277,082 shares of the stock traded hands, compared to its average volume of 379,533. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.47 and a current ratio of 1.96. The company has a market cap of $3.37 billion, a PE ratio of 53.86, a PEG ratio of 2.65 and a beta of 1.20. Omnicell, Inc. has a 1 year low of $45.15 and a 1 year high of $86.87.

Omnicell (NASDAQ:OMCL) last posted its quarterly earnings results on Thursday, April 25th. The company reported $0.61 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.23 by $0.38. Omnicell had a return on equity of 11.10% and a net margin of 4.74%. The business had revenue of $202.50 million for the quarter, compared to the consensus estimate of $199.72 million. During the same quarter in the previous year, the business earned $0.29 EPS. The company’s quarterly revenue was up 10.9% compared to the same quarter last year. As a group, analysts predict that Omnicell, Inc. will post 2.06 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “Omnicell, Inc. (NASDAQ:OMCL) Shares Bought by Louisiana State Employees Retirement System” was posted by Baseball Daily News and is owned by of Baseball Daily News. If you are accessing this piece of content on another publication, it was copied illegally and republished in violation of US and international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.baseballdailydigest.com/news/2019/05/11/omnicell-inc-omcl-shares-bought-by-louisiana-state-employees-retirement-system.html.

About Omnicell

Omnicell, Inc provides medication and supply dispensing automation, central pharmacy automation, analytics software, and medication adherence solutions for the healthcare industry worldwide. It operates in two segments, Automation and Analytics, and Medication Adherence. The Automation and Analytics segment offers central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System, a building block of autonomous pharmacy vision; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems.

Featured Article: Outstanding Shares, Buying and Selling Stocks

Institutional Ownership by Quarter for Omnicell (NASDAQ:OMCL)

Receive News & Ratings for Omnicell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omnicell and related companies with MarketBeat.com's FREE daily email newsletter.